RE:4 Trials NMIBCInteresting excerpt from the HTBX website:
"The recent approvals of anti-CTLA-4 (Yervoy) and anti-PD-1 (Opdivo, Kytruda) antibodies have unequivocally demonstrated that the human immune system can cure cancer. These drugs have provided hope to patients with late-stage melanoma, non-small cell lung cancer, bladder cancer and led to the emergence of a whole new class of medicines.
Unfortunately, clinical responses to these drugs only occur in a minority of patients."